OFF-BRAND IMATINIB: A COST-EFFECTIVE ALTERNATIVE?

The introduction of off-brand imatinib represents a substantial possibility for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a considerable price label, frequently causing accessibility for some individuals. Gen